JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 20, 2005; DOI: 10.1124/jpet.105.090738


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.090738v1
316/1/248    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paulson, J. R.
Right arrow Articles by Abbruscato, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paulson, J. R.
Right arrow Articles by Abbruscato, T. J.


Received for publication June 8, 2005.
Revised September 15, 2005.
Accepted for publication September 16, 2005.

Tobacco Smoke Chemicals Attenuate Brain-to-Blood Potassium Transport Mediated by the Na,K,2Cl-Cotransporter During Hypoxia-Reoxygenation

Jennifer R. Paulson 1, Karen E. Roder 1, Ghia McAfee 1, David D. Allen 1, Cornelis J. Van der Schyf 1, Thomas J. Abbruscato 1*

1 Texas Tech University Health Sciences Center: School of Pharmacy

* Address correspondence to: E-mail: thomas.abbruscato{at}ttuhsc.edu

Abstract

Smoking tobacco, including cigarettes, has been associated with an increased incidence and relative risk for cerebral infarction in both men and women. Recently, we have shown that nicotine and cotinine attenuate abluminal (brain facing) K+ uptake mediated by the Na,K,2Cl-cotransporter (NKCC) in bovine brain microvessel endothelial cells (BBMECs) after hypoxic/aglycemic exposure (stroke conditions). The purpose of the current study was to explore the effects of nicotine and tobacco smoke chemicals on K+ movement through the blood-brain barrier during both hypoxia/aglycemia and reoxygenation. BBMECs were exposed to nicotine/cotinine, nicotine-containing cigarette smoke extract (N-CSE), or nicotine-free cigarette smoke extract (NF-CSE) in quantities designed to mimic plasma concentrations of smokers. Stroke conditions were mimicked in vitro in BBMECs through 6 hr hypoxia/aglycemia with or without 12 hr reoxygenation, after which NKCC-mediated K+ uptake and paracellular integrity were measured with 86Rb and 14C-sucrose, respectively. In addition, K+ concentrations in brain extracellular fluid were estimated in 86Rb injected rats that were administered nicotine, N-CSE, or NF-CSE and on whom global ischemia/reperfusion by in vivo four vessel occlusion was performed. Both in vitro and in vivo paradigms showed nicotine, the major alkaloid present in tobacco smoke, to be the determining factor of an inhibited response of abluminal NKCC in BBMECs during and after stroke conditions. This was measured as a decrease in abluminal brain endothelial cell NKCC activity, and as an increase in brain extracellular K+ concentration measured as the brain extracellular fluid 86 Rb-to-plasma ratio after in vivo four vessel occlusion with reperfusion.


Key words: Blood-Brain Barrier, Na, K, 2Cl-cotransporter, cigarette smoke extract, nicotine, potassium, stroke





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.